Arkolith/Insider Trading/CORT/Form 4

Guyer William

Chief Development OfficerCORCEPT THERAPEUTICS INC (CORT) · full profile →Form 4 · filed Jun 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)20K$21.65$433K24K
Jun 2, 2026Sell(S)20K$70.60$1.4M4K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 2, 2026Option exercise(M)20K—$0150K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-257618) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML